000 01081 a2200301 4500
005 20250518014835.0
264 0 _c20190930
008 201909s 0 0 eng d
022 _a1866-0452
024 7 _a10.3238/arztebl.2018.0776
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAltiok, Ertunc
245 0 0 _aOral Anticoagulation.
_h[electronic resource]
260 _bDeutsches Arzteblatt international
_cNov 2018
300 _a776-783 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aAnticoagulants
_xpharmacology
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aHeart Valve Prosthesis
_xadverse effects
650 0 4 _aHumans
650 0 4 _aRisk Assessment
_xmethods
650 0 4 _aVenous Thromboembolism
_xdrug therapy
650 0 4 _aVitamin K
_xantagonists & inhibitors
700 1 _aMarx, Nikolaus
773 0 _tDeutsches Arzteblatt international
_gvol. 115
_gno. 46
_gp. 776-783
856 4 0 _uhttps://doi.org/10.3238/arztebl.2018.0776
_zAvailable from publisher's website
999 _c29214140
_d29214140